Keywords
Volatile organic compounds
Depression
NHANES
Categories
How to Cite
Abstract
Background and Aim: Environmental exposure to volatile organic compounds (VOCs) is linked to depressive disorder, examined as a unitary outcome. Symptom-specific observations are scarce. Anhedonia, a representative phenotype in depression, has unique biology from negative valences. Here, we aim to investigate associations between urinary metabolites of VOCs (UVOCs) and anhedonia. Methods: We analyzed 5,084 adults from five cycles of National Health and Nutrition Examination Survey (NHANES) over a decade. Anhedonia was assessed by the first item of the Patient Health Questionnaire-9. Fifteen UVOCs included were selected based on their importance by multivariate logistic regression, elastic net, and random forest models. Dose-response relationships were examined by generalized additive models and restricted cubic splines. Mixed exposure was evaluated by environmental risk score and weighted quantile sum regression. Mechanisms were explored by mediation analysis. Results: We found six UVOCs with strong links to anhedonia: four positive (MHBMA3, DHBMA, MA, 3HPMA) and two inverse (2MHA, 2HPMA). Positively associated UVOCs exhibited J-shaped dose-response relationships with anhedonia, while inversely associated ones showed reverse patterns. Mixed exposure was positively connected to anhedonia, with DHBMA (metabolite of 1,3-butadiene) still contributing the most. A nomogram was developed for risk estimation based on UVOC concentrations. Mechanistically, white blood cells and neutrophils acted as detrimental mediators, lymphocytes and monocytes as protective ones, whereas albumin showed suppression effects. Conclusions: We report the symptom-specific associations between certain VOC exposure and anhedonia. These findings may propose environmental predictors of anhedonia and advance precision approaches in psychiatric epidemiology.
References
[1] Huang X, Zhang Y, Yang W, et al. Effect of traffic restriction on reducing ambient volatile organic compounds (VOCs): observation-based evaluation during a traffic restriction drill in Guangzhou, China. Atmos Environ. 2017;161:61-70. https://doi.org/10.1016/j.atmosenv.2017.04.035
[2] Li AJ, Pal VK, Kannan K. A review of environmental occurrence, toxicity, biotransformation and biomonitoring of volatile organic compounds. Environ Chem Ecotoxicol. 2021;3:91-116. https://doi.org/10.1016/j.enceco.2021.01.001
[3] Zeliger HI. Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases. Interdiscip Toxicol. 2014;6:103-110. https://doi.org/10.2478/intox-2013-0018
[4] Alwis KU, Blount BC, Britt AS, et al. Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal Chim Acta. 2012;750:152-160. https://doi.org/10.1016/j.aca.2012.04.009
[5] Fujita A, Okuno T, Oda M, et al. Urinary volatilome analysis in a mouse model of anxiety and depression. PLoS One. 2020;15:e0229269. https://doi.org/10.1371/journal.pone.0229269
[6] Zhuang Y, Li L, Zhang Y, et al. Associations of exposure to volatile organic compounds with sleep health and potential mediators: analysis of NHANES data. Front Public Health. 2024;12:1423771. https://doi.org/10.3389/fpubh.2024.1423771
[7] Wang F, Fangfang Z, Guo X, et al. Effects of volatile organic compounds and carbon monoxide mixtures on learning and memory, oxidative stress, and monoamine neurotransmitters in the brains of mice. Toxicol Ind Health. 2018;34:178-187. https://doi.org/10.1177/0748233717747504
[8] Zhuang Y, Zhang X, Sun X, et al. Association of environmental volatile organic compounds with depression in adults: NHANES 2013-2018. Hyg Environ Health Adv. 2023;6:100058. https://doi.org/10.1016/j.heha.2023.100058
[9] Tang L, Liu M, Tian J. Volatile organic compounds exposure associated with depression among U.S. adults: Results from NHANES 2011-2020. Chemosphere. 2024;349:140690. https://doi.org/10.1016/j.chemosphere.2023.140690
[10] Ma T, Wang X, He W, et al. Expose to volatile organic compounds is associated with increased risk of depression: a cross-sectional study. J Affect Disord. 2024;363:239-248. https://doi.org/10.1016/j.jad.2024.07.028
[11] Shen Q, Liu Y, Li G, et al. A review of disrupted biological response associated with volatile organic compound exposure: insight into identification of biomarkers. Sci Total Environ. 2024;948:174924. https://doi.org/10.1016/j.scitotenv.2024.174924
[12] Hu Y, Niu Z, Cao C, et al. Volatile organic compounds (VOC) metabolites in urine are associated with increased systemic inflammation levels, and smokers are identified as a vulnerable population. Ecotoxicol Environ Saf. 2024;288:117398. https://doi.org/10.1016/j.ecoenv.2024.117398
[13] World Health Organization. Depressive disorder (depression). World Health Organization Fact Sheets. Geneva: WHO Press; 2023. https://www.who.int/news-room/fact-sheets/detail/depression
[14] GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133-2161. https://doi.org/10.1016/S0140-6736(24)00757-8
[15] Santomauro DF, Vos T, Whiteford HA, et al. Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021. Lancet Psychiatry. 2024;11:1012-1021. https://doi.org/10.1016/S2215-0366(24)00317-1
[16] Fried EI, Nesse RM. Depression sum-scores don't add up: why analyzing specific depression symptoms is essential. BMC Med. 2015;13:72. https://doi.org/10.1186/s12916-015-0325-4
[17] Kaltenboeck A, Harmer C. The neuroscience of depressive disorders: A brief review of the past and some considerations about the future. Brain Neurosci Adv. 2018;2:2398212818799269. https://doi.org/10.1177/2398212818799269
[18] Serretti A. Anhedonia and depressive disorders. Clin Psychopharmacol Neurosci. 2023;21:401-409. https://doi.org/10.9758/cpn.23.1086
[19] Trøstheim M, Eikemo M, Meir R, et al. Assessment of Anhedonia in Adults With and Without Mental Illness: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3:e2013233. https://doi.org/10.1001/jamanetworkopen.2020.13233
[20] Wong S, Le GH, Phan L, et al. Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis. J Affect Disord. 2024;330:99-120. https://doi.org/10.1016/j.jad.2024.04.086
[21] Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry. 2006;59:1151-1159. https://doi.org/10.1016/j.biopsych.2005.09.018
[22] Bekhbat M, Li Z, Mehta ND, et al. Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study. Mol Psychiatry. 2022;27:4113-4121. https://doi.org/10.1038/s41380-022-01715-3
[23] Dodell-Feder D, Germine L. Epidemiological Dimensions of Social Anhedonia. Clin Psychol Sci. 2018;6:735-743. https://doi.org/10.1177/2167702618773740
[24] Comai S, Manchia M, Bosia M, et al. Moving toward precision and personalized treatment strategies in psychiatry. Int J Neuropsychopharmacol. 2025;28:pyaf025. https://doi.org/10.1093/ijnp/pyaf025
[25] National Center for Health Statistics. Research Ethics Review Board (ERB) Approval. Centers for Disease Control and Prevention; 2024. https://www.cdc.gov/nchs/nhanes/about/erb.html
[26] Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
[27] Iranpour S, Sabour S. Inverse association between caffeine intake and depressive symptoms in US adults: data from National Health and Nutrition Examination Survey (NHANES) 2005-2006. Psychiatry Res. 2019;271:732-739. https://doi.org/10.1016/j.psychres.2018.11.004
[28] Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. Can Med Assoc J. 2012;184:E191-E196. https://doi.org/10.1503/cmaj.110829
[29] Dong L, Xie Y, Zou X. Association between sleep duration and depression in US adults: A cross-sectional study. J Affect Disord. 2022;296:183-188. https://doi.org/10.1016/j.jad.2021.09.075
[30] Wu L, Zhang J, Xin Y, et al. Associations between phenols, parabens, and phthalates and depressive symptoms: The role of inflammatory markers and bioinformatic insights. Ecotoxicol Environ Saf. 2024;286:117191. https://doi.org/10.1016/j.ecoenv.2024.117191
[31] Whooley MA, Avins AL, Miranda J, et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12:439-445. https://doi.org/10.1046/j.1525-1497.1997.00076.x
[32] Wang X, He W, Wu X, et al. Exposure to volatile organic compounds is a risk factor for diabetes: A cross-sectional study. Chemosphere. 2023;338:139424. https://doi.org/10.1016/j.chemosphere.2023.139424
[33] Dong H, Wang X, Xiao N, et al. Association between volatile organic compounds exposure and periodontitis: A representative cross-sectional study. J Clin Periodontol. 2024;51:1359-1368. https://doi.org/10.1111/jcpe.14041
[34] Akinbami LJ, Chen TC, Davy O, et al. National Health and Nutrition Examination Survey, 2017-March 2020 prepandemic file: Sample design, estimation, and analytic guidelines. National Center for Health Statistics. Vital Health Stat 2. 2022;(190). https://dx.doi.org/10.15620/cdc:115434
[35] He H, Sun Z, Chen X, et al. Exposure to volatile organic compounds and suicidal ideation: Insights from a U.S. population-based study. J Affect Disord. 2025;379:194-203. https://doi.org/10.1016/j.jad.2025.03.049
[36] Li E, Ai F, Liang C. A machine learning model to predict the risk of depression in US adults with obstructive sleep apnea hypopnea syndrome: a cross-sectional study. Front Public Health. 2024;11:1348803. https://doi.org/10.3389/fpubh.2023.1348803
[37] Servén D, Brummitt C. pyGAM: Generalized Additive Models in Python. Zenodo; 2018. https://doi.org/10.5281/zenodo.1208723
[38] Park SK, Zhao Z, Mukherjee B. Construction of environmental risk score beyond standard linear models using machine learning methods: application to metal mixtures, oxidative stress and cardiovascular disease in NHANES. Environ Health. 2017;16:102. https://doi.org/10.1186/s12940-017-0310-9
[39] Wu M, Liu M, Zhang Y, et al. Serum HDL partially mediates the association between exposure to volatile organic compounds and kidney stones: A nationally representative cross-sectional study from NHANES. Sci Total Environ. 2024;907:167915. https://doi.org/10.1016/j.scitotenv.2023.167915
[40] Wang X, Chen Z, Cheng D, et al. Association between urinary metabolites of volatile organic compounds and cardiovascular disease in the general population from NHANES 2011-2018. Ecotoxicol Environ Saf. 2023;264:115412. https://doi.org/10.1016/j.ecoenv.2023.115412
[41] Kong X, Qiu Z. Correlation of exposure to volatile organic compounds with myocardial infarction: A Cross-sectional study based on NHANES 2011-2018. Sci Rep. 2025;15:17736. https://doi.org/10.1038/s41598-025-01773-x
[42] Ni J, Song W, Wang K, et al. Identifying effects of volatile organic compounds exposure on kidney stone prevalence in U.S. adults: a cross-sectional analysis of NHANES 2007-2020. BMC Public Health. 2024;24:2727. https://doi.org/10.1186/s12889-024-20251-z
[43] Lin YL, Yang YC. Volatile organic compound exposure is associated with hyperuricemia in the general population: an analysis of 6878 adults from the NHANES. Metabolomics. 2025;21:60. https://doi.org/10.1007/s11306-025-02261-z
[44] Zhou L, Wu D, Chen H, et al. Association between urinary volatile organic compounds metabolites and rheumatoid arthritis among the adults from NHANES 2011-2018. Sci Rep. 2024;14:31025. https://doi.org/10.1038/s41598-024-82202-3
[45] Qu TZ, Zhang Y, Huang QY, et al. Exposure to volatile organic compounds and sarcopenia risk in US adults based on NHANES. Sci Rep. 2025;15:25480. https://doi.org/10.1038/s41598-025-11628-0
[46] Zhou H, Cui Z, Di D, et al. Connecting volatile organic compounds exposure to osteoporosis risk via oxidative stress based on adverse outcome pathway methodology. J Environ Sci. 2025;155:806-817. https://doi.org/10.1016/j.jes.2024.09.010
[47] Dubovsky SL, Ghosh BM, Serotte JC, et al. Psychotic Depression: Diagnosis, Differential Diagnosis, and Treatment. Psychother Psychosom. 2021;90:160-177. https://doi.org/10.1159/000511348
[48] Olgiati P, Luca M, Luca A, et al. Passive suicide ideation in major depressive disorder: prognostic role and effect of antidepressant treatment. J Psychiatr Res. 2025;189:445-454. https://doi.org/10.1016/j.jpsychires.2025.06.012
[49] Behr GA, da Motta LL, de Oliveira MR, et al. Decreased anxiety-like behavior and locomotor/exploratory activity, and modulation in hypothalamus, hippocampus, and frontal cortex redox profile in sexually receptive female rats after short-term exposure to male chemical cues. Behav Brain Res. 2009;199:263-270. https://doi.org/10.1016/j.bbr.2008.11.047
[50] Smith MT. Advances in understanding benzene health effects and susceptibility. Annu Rev Public Health. 2010;31:133-148. https://doi.org/10.1146/annurev.publhealth.012809.103646
[51] Li H, Zhang Z, Xu Q, et al. Integrated transcriptomic and proteomic analyses reveal the effects of chronic benzene exposure on the central nervous system in mice. Toxicol Mech Methods. 2025;35:101-112. https://doi.org/10.1080/15376516.2024.2387740
[52] Jarry H, Metten M, Gamer AO, et al. Effects of 5-day styrene inhalation on serum prolactin and dopamine levels and on hypothalamic and striatal catecholamine concentrations in male rats. Arch Toxicol. 2002;76:657-663. https://doi.org/10.1007/s00204-002-0386-y
[53] Gagnaire F, Chalansonnet M, Carabin N, et al. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain. Arch Toxicol. 2006;80:703-712. https://doi.org/10.1007/s00204-006-0083-3
[54] Urban M, Gilch G, Schepers G, et al. Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. J Chromatogr B. 2003;796:131-140. https://doi.org/10.1016/j.jchromb.2003.08.009
[55] Chen WQ, Zhang XY. 1,3-Butadiene: a ubiquitous environmental mutagen and its associations with diseases. Genes Environ. 2022;44:3. https://doi.org/10.1186/s41021-021-00233-y
[56] Csanády GA, Kreuzer PE, Baur C, et al. A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts—relevance of glutathione depletion. Toxicology. 1996;113:300-305. https://doi.org/10.1016/0300-483X(96)03461-0
[57] Hartman JH, Miller GP, Caro AA, et al. 1,3-Butadiene-induced mitochondrial dysfunction is correlated with mitochondrial CYP2E1 activity in Collaborative Cross mice. Toxicology. 2017;378:114-124. https://doi.org/10.1016/j.tox.2017.01.005
[58] von Ehrenstein OS, Aralis H, Cockburn M, et al. In utero exposure to toxic air pollutants and risk of childhood autism. Epidemiology. 2014;25:851-858. https://doi.org/10.1097/EDE.0000000000000150
[59] Han SY, Lee SY, Suh MW, et al. Higher exposure to 1,3-butadiene is associated with more severe hearing loss. Sci Rep. 2024;14:12899. https://doi.org/10.1038/s41598-024-63757-7
[60] Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012;35:68-77. https://doi.org/10.1016/j.tins.2011.11.005
[61] National Institute for Occupational Safety and Health. Carcinogenic Effects of Exposure to Propylene Oxide. DHHS (NIOSH) Publication Number 89-111; 1989. https://www.cdc.gov/niosh/docs/89-111/default.html
[62] Setzer JV, Brightwell WS, Russo JM, et al. Neurophysiological and neuropathological evaluation of primates exposed to ethylene oxide and propylene oxide. Toxicol Ind Health. 1996;12:667-682. https://doi.org/10.1177/074823379601200506
[63] Nguyen HD. Effects of a mixture of ambient air pollution and its metabolites on depression: From epidemiology to molecular mechanisms. J Environ Sci. 2025;158:405-419. https://doi.org/10.1016/j.jes.2025.02.015
[64] Palmer BF, Clegg DJ. Metabolic Flexibility and Its Impact on Health Outcomes. Mayo Clin Proc. 2022;97:761-776. https://doi.org/10.1016/j.mayocp.2022.01.012
[65] Liu MY, Yin CY, Zhu LJ, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 2018;13:1686-1698. https://doi.org/10.1038/s41596-018-0011-z
[66] Jorgensen D, White GE, Sekikawa A, et al. Higher dietary inflammation is associated with increased odds of depression independent of Framingham Risk Score in the National Health and Nutrition Examination Survey. Nutr Res. 2018;54:23-32. https://doi.org/10.1016/j.nutres.2018.03.004
[67] Ogbodo JO, Arazu AV, Iguh TC, et al. Volatile organic compounds: A proinflammatory activator in autoimmune diseases. Front Immunol. 2022;13:928379. https://doi.org/10.3389/fimmu.2022.928379
[68] Chakraborty S, Tabrizi Z, Bhatt NN, et al. A Brief Overview of Neutrophils in Neurological Diseases. Biomolecules. 2023;13:743. https://doi.org/10.3390/biom13050743
[69] Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1-12. https://doi.org/10.1016/j.bbi.2016.03.010
[70] Nikolopoulos D, Manolakou T, Polissidis A, et al. Microglia activation in the presence of intact blood-brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus. Ann Rheum Dis. 2023;82:646-657. https://doi.org/10.1136/ard-2022-223506
[71] Guo J, Garshick E, Si F, et al. Environmental Toxicant Exposure and Depressive Symptoms. JAMA Netw Open. 2024;7:e2420259. https://doi.org/10.1001/jamanetworkopen.2024.20259
[72] Gendelman HE, Appel SH. Neuroprotective activities of regulatory T cells. Trends Mol Med. 2011;17:687-688. https://doi.org/10.1016/j.molmed.2011.08.005
[73] Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233:6425-6440. https://doi.org/10.1002/jcp.26429
[74] Kreitinger JM, Beamer CA, Shepherd DM. Environmental Immunology: Lessons Learned from Exposure to a Select Panel of Immunotoxicants. J Immunol. 2016;196:3217-3225. https://doi.org/10.4049/jimmunol.1502149
[75] Geng Z, Zhou Q, Guo M, et al. Imaging human serum albumin behavior in process of PVOCs transportation in vivo: Spectroscopy analysis insight. Food Chem. 2022;396:133692. https://doi.org/10.1016/j.foodchem.2022.133692
[76] Wanat K. Biological barriers, and the influence of protein binding on the passage of drugs across them. Mol Biol Rep. 2020;47:3221-3231. https://doi.org/10.1007/s11033-020-05361-2
[77] You M, Ding Y, Wei Z, et al. Creation and verification of a predictive nomogram model for the incidence of social isolation among China's older population. Front Public Health. 2025;13:1571509. https://doi.org/10.3389/fpubh.2025.1571509
[78] Snaith RP, Hamilton M, Morley S, et al. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995;167:99-103. https://doi.org/10.1192/bjp.167.1.99
[79] Gard DE, Kring AM, Gard MG, et al. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007;93:253-260. https://doi.org/10.1016/j.schres.2007.03.008
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Frontiers in Preventive Medicine